
Home » ANDRX STOCKHOLDERS OK WATSON BUY
ANDRX STOCKHOLDERS OK WATSON BUY
Andrx Corp. shareholders have approved Watson Pharmaceuticals to buy the company. At a special meeting earlier Wednesday, the holders in Fort Lauderdale-based Andrx adopted the agreement and merger plan Andrx entered with Corona, Calif.-based Watson Pharmaceuticals entered March 12.
The South Florida Business Journal (http://phoenix.bizjournals.com/southflorida/stories/2006/06/26/daily37.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
13Dec
-
14Apr